Enhertu Approved for HER2-Low Metastatic Breast Cancer
The Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), a HER2-directed antibody and topoisomerase inhibitor conjugate, for the treatment...
The Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), a HER2-directed antibody and topoisomerase inhibitor conjugate, for the treatment...
BioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October. The German biotech firm, which makes the...
The Food and Drug Administration (FDA) has approved Nubeqa® (darolutamide), an androgen receptor inhibitor, in combination with docetaxel for the...
People who are severely ill with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are often too sick to leave home, but clinicians...
There’s really no ignoring the inexorable math that led the Senate to approve a plan that will give Medicare unprecedented...
James (Jim) R. Roberts, MD, whose 45-year career spanned the evolution of the field of emergency medicine (EM) as it...
Climate hazards such as flooding, heat waves, and drought have worsened more than half of the hundreds of known infectious...
Home » Specialties » Dermatology In rhinoplasty, surgeons modify the osseocartilaginous framework (OCF) to achieve optimal aesthetical and functional results....
Raising phototherapy thresholds and revising risk assessment are among the key changes in the American Academy of Pediatrics' updated guidelines...
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow of money through the health...
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.